Tag: CE

Unforgettable moments, laughter, discovery, and joy.
The Lyric Stage 2022/23 Season is a season to share.

The Lyric Stage Company of Boston has created a season of plays that will inspire audiences to share in one-of-a-kind experiences that only live theater can create.  It’s a season to gather together and connect with the friends we come with and the ones we make in the seat next to us. That spark of inspiration, delight, and joy awaits you as the lights go down and the spotlight comes up on stories that are at the core of what it means to be in this world together.

“For as long as I’ve been a part of Lyric Stage I’ve always enjoyed and trusted their selection of plays, writers, artists, musicians, directors, designers, and everyone that it takes to put on a show. And over the years of enjoying Lyric Stage, I have gotten to know the people involved and to thank them personally for the joy, smiles and all of the other emotions I experience while they stand on the stage or behind the stage, telling the story. I love every season that I can remember, and I thought it was time to make my statement.,” says Season Sponsor, Paul Kastner.

Artistic Director Courtney O’Connor says, “When thinking of what stories we all need moving forward, the word that kept rising to the surface was ‘joy.’ Whether it’s a group of people coming together to create art, rediscovering who you are—or discovering it for the first time, or making a surprising connection, our 2022/23 season is filled with moments of joy and delight featuring some of your favorite Lyric Stage artists (some in new roles) and new artists we can’t wait to introduce to you.”

Executive Director Matt Chapuran says, “After two years of physical distancing, it’s moving to have opportunities to draw us close once again. These six plays are all distinct from one another, each one offering a different opportunity to share an evening of theater with a close friend or family member. But regardless of what emotional or intellectual response we achieve, we hope that all our guests in the coming year experience joy at Lyric Stage. That’s especially true for the residents of 140 Clarendon Street, with whom we are proud to call this historic building home.”

FABULATION OR, THE RE-EDUCATION OF UNDINE
By Lynn Nottage
Directed by Dawn M. Simmons
September 16-October 9, 2022

From the penthouse to mom’s house. A riches-to-rags story asking “can you ever really go home again?”

Success. Love. Fabulous wardrobe. Undine has it all. Until her husband steals her hard-earned fortune, sending her tumbling down the social ladder. Pregnant and penniless, with life unraveling at every turn, Undine is forced to return home to Brooklyn and the family she left behind, in a crude new reality. In this satirical comedy by two-time Pulitzer Prize-winner Lynn Nottage (Intimate Apparel, Meet Vera Stark, Sweat) while life unravels, hope can be found in small victories and in the discovery of finding happiness within.

THE PLAY THAT GOES WRONG
By Henry Lewis, Jonathan Sayer & Henry Shields
Directed by Fred Sullivan Jr.
November 11-December 4, 2022

It’s so bad, it’s good.

“Break a leg!” takes on a whole new meaning for a woefully misguided troupe of players at the Cornley University Society’s opening night performance of The Murder at Haversham Manor. An unconscious leading lady, a corpse who can’t play dead, a ruffled detective, and a word-mangling butler (among others) must battle against technical gaffes, forgotten lines, and sabotaging scenery in a quest to arrive all in one piece at the final curtain call. Part Monty Python, part Sherlock Holmes, all mayhem, this 1920s whodunit is disastrously delightful.

PRELUDES
By Dave Malloy
Directed by Courtney O’Connor
Music Director Dan Rodriguez
January 6-29, 2023

“I just want to be remembered.”

A musical fantasia, Preludes unfolds in the hypnotized mind of composer and virtuoso pianist Sergei Rachmaninoff as he attempts to overcome his writer’s block following a disastrous premiere of his Symphony No. 1 in D minor. In an array of hypnotic reveries, he is invigorated by some of the most influential artists of the time including Tolstoy, Chekhov, and Tchaikovsky. Creativity is unlocked and ignited through Dave Malloy’s (Natasha, Pierre & The Great Comet of 1812) bewitching mashup of original compositions and Rachmaninoff’s own work that takes us on a glorious journey on an artist’s quest to secure a legacy and reclaim a voice.

THE GREAT LEAP
By Lauren Yee
Directed by Michael Hisamoto
February 24-March 19, 2023

Every game is a second chance.

It’s 1989 San Francisco and Manford Lum, a gifted, fast-talking teenager, dominates the high school basketball courts. Facing an uncertain future, he convinces Saul, a cynical and crusty coach, to let him travel to Beijing for a “friendship” game in China. Waiting there is a Chinese national coach with unfinished business, both with Saul and with Manford. On the eve of historic demonstrations, all three men are challenged to define their pasts and their futures.

SISTER ACT
Music by Alan Menken
Lyrics by Glenn Slater
Book by Bill and Cheri Steinkellner with additional material by Douglas Carter Beane
Directed by Leigh Barrett
April 7-30, 2023

And then there were nuns. A divine, feel-good musical comedy.

After witnessing a murder, free spirited, disco diva Deloris Van Cartier finds herself in protective custody at a convent. At odds with a rigid Mother Superior, and a strict lifestyle, Deloris finds divine intervention bringing the choir from dour to dazzling with her signature style. While Deloris busy raising the roof, her cover is blown and her new found sisterhood rallies around her with a lot of love (and maybe a few sequins) in a tribute to the power of friendship.

ROOTED
By Deborah Zoe Laufer
Directed by Courtney O’Connor
June 2-25, 2023

When you find yourself  up a tree, something is bound to take root.  An offbeat comedy about connecting in a chaotic world.

In the claustrophobic town of Millerville, Emery Harris lives alone in a treehouse named Mabel surrounded by a dozen or so plants she researches, names, and talks to. Her overbearing sister Hazel is Emery’s only connection to reality along with her YouTube channel where she documents her studies that have garnered several thousand followers. When her calm and quiet is disrupted by an entourage of devotees chanting and singing to her – their botanical, new-age messiah –-she is forced to look down from the branches and face the outside world.

Season Sponsor: Paul Kastner

History of the Lyric Stage Company of Boston

Founded in 1974 and in residence at 140 Clarendon Street since 1991, the Lyric Stage Company is Boston’s oldest resident theater company. Its mission is to produce and present live theater in Greater Boston with an intimate approach that promotes inclusivity and connection. The Lyric Stage leads an effort to integrate live theater and theater education into the lives of all residents of greater Boston. In 2021, the Lyric Stage signed a new long-term lease with Beacon Communities, the new owners of 140 Clarendon Street. www.lyricstage.com

Bozeman, April 25, 2022 – Alercell, announced today that it will begin distributing a Leukemia Fusion Gene Screening and Genotyping Kit created and manufactured by Zeesan, a longtime partner of Alercell.

Leukemia, commonly known as blood cancer, is a malignant disease of the blood system. The innovative approach of the Leukemia Fusion Gene Kit is to target the gene mutations, the clonogenic gene rearrangements and abnormal gene expression. Fusion genes are one of the most common biomarkers in Leukemia and are caused by chromosome breakage and recombination. More than 200 types of fusion genes have been identified, and about 50% of leukemia patients have fusion gene biomarkers, and different disease subtypes have different fusion gene profiles.

The Zeesan approach allows the screening of up to 55 types of leukemia fusion genes. The screening allows a more precise medication, precisely targeting the relevant genes.  This allows a timely adjustment of treatment schedule and signals potential relapse warnings.

“One valuable aspect is the unique combination of accuracy and speed” said Dr. Alexandre Scheer MD Chief Medical Officer of Alercell. “The approach is not only innovative but could mean tremendous savings in terms of time and money for treating Leukemia. The traditional approach is done through blood tests and bone marrow biopsy, while the Zeesan Leukemia Fusion Gene Screening and Genotyping Kit is a kit that is analyzed through a standard PCR machine”. Results can be obtained in a few hours at a fraction of the costs of the traditional approach.

“Using a genetic approach and using our knowledge of the genome is definitively the medicine of the 21^st century,” said Frederic Scheer, Alercell CEO. “It is important to give practitioners and patients a fast and affordable solution to all the life-threatening conditions that are ravaging the lives of so many.”

The Leukemia Fusion Gene Screening and Genotyping Kit will start as a “RUO” Research Use Only while waiting for the final FDA certification to expand the distribution around the country.

ABOUT ALERCELL

Alercell is a Biotechnology company specialized in infectious diseases, and in-vitro diagnostics tests for cancer, based in Bozeman, Montana with a satellite office in New York City. Created by a group of veterans of medical research, Alercell’s core business is in the discovery, development, distribution, manufacture, and sale of efficient treatment for infectious diseases including the Coronavirus and cancer prevention diagnostic testing. For more information, please visit: www.alercell.com

Forward Looking Statements

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Alercell ‘s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include the inability to complete the proposed business combination or the Extension; the inability to recognize the anticipated benefits of the proposed business combination; costs related to any business combination; Alercell’s ability to manage growth; Alercell’s ability to execute its business plan; the timing of revenues from existing customers, including uncertainties related to the ability of Alercell’s customers to commercialize their products and the ultimate market acceptance of these products; the uncertain impact of the COVID-19 pandemic on Alercell’s and its customers’ businesses; uncertainties related to Alercell’s estimates of the size of the markets for its products; the rate and degree of market acceptance of Alercell ‘s products; the success of other competing products and services that exist or may become available; Alercell’s ability to identify and integrate acquisitions; rising costs adversely affecting Alercell’s profitability; uncertainties related to Alercell’s potential litigation involving Alercell or the validity or enforceability of Alercell’s intellectual property; and general economic and market conditions impacting demand for Alercell’s products and services. Other factors include the possibility that any proposed business combination does not close, including due to the failure to receive required security holder approvals, or the failure of other closing conditions. Alercell does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Disclaimer

This release shall neither constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

(Brawley, CA) April 22, 2022 — California Ethanol and Power (CE+P) today announced it has advanced through Part I of the U.S. Department of Energy’s (“DOE”) Loan Programs Office Title XVII Innovative Energy Loan Guarantee Program and Renewable Energy Projects and Efficient Energy Projects Solicitation, a rigorous first stage of consideration to qualify projects eligible for the program. As a result, CE+P has been invited to submit a Part II Application for a Federal Loan Guarantee, according to Ron Blake, California Ethanol + Power’s Chief Financial Officer.

“This important milestone demonstrates that Sugar Valley Energy meets the rigorous initial evaluation standards set by the Department of Energy for innovation in renewable energy, as an invitation to Part II is not something the Loan Programs Office extends lightly,” said Ron Blake. “Advanced biofuels represent a critical part of our nation’s energy future, and domestically produced sugarcane ethanol will provide a quality renewable resource to meet our energy needs with much lower carbon intensity than imported sources.”

If awarded, the DOE loan would be used for construction of Sugar Valley Energy, California Ethanol + Power’s planned and permitted 160-acre campus, combining an advanced ethanol biorefinery, bioelectric and biogas generation along with wastewater treatment facilities in Imperial County, CA.

CE+P is currently in the process of securing equity and bond financing for Sugar Valley Energy, with construction expected to begin this year.

The sugarcane ethanol to be produced at Sugar Valley Energy is expected to have a Carbon Intensity (CI) score considerably lower than today’s domestically produced corn ethanol, and the planned biorefinery will incorporate next-generation measures to reduce emissions throughout its operation.

A significant part of California Ethanol + Power’s vision for Sugar Valley Energy is to contract with local agricultural producers to establish an estimated 48,000 acres of sugarcane production in the Imperial Valley. The sugarcane feedstock will produce more than 70 million gallons of low-carbon ethanol each year along with up to 49 Megawatts of electrical power, helping meet California’s established emissions reduction, renewable energy, and low-carbon energy goals.

CE+P has obtained all the major necessary permits and environmental certifications for the development of the Sugar Valley Energy project and has entered into a long-term purchase and marketing agreement with agribusiness leader CHS, Inc. to sell the ethanol produced at the new energy campus.

According to a third-party economic analysis, Sugar Valley Energy is projected to have a $1.7 billion positive economic impact through construction and year one of operations, and support more than 15,000 direct and indirect jobs in the surrounding region over the same period. The development of Sugar Valley Energy will also establish critical infrastructure for future growth in Imperial Valley by delivering access to a critical water treatment plant and energy capacity nearby.

PLEXUS Solutions is advising Sugar Valley Energy on its loan guarantee application with the DOE. PLEXUS provides Advisory and Investment Management services to clients in the Sustainability Infrastructure industry. The core focus is evaluating and implementing capital solutions for Sustainable Asset Developers, Manufacturers, Institutional Investors, Family Offices and Service Providers. PLEXUS is based in New York and San Francisco. More information is available at www.plexussolutions.services.

DOE Loan Programs Office Disclaimer

The DOE Loan Programs Office (LPO) invitation to California Ethanol +Power to submit a Part II application for a loan guarantee reflects LPO’s determination that the project satisfies the technical eligibility requirements set forth in the applicable LPO solicitation, based on the materials submitted to DOE as of the date of its determination. DOE’s invitation to submit a Part II application is not, however, an assurance that DOE will invite CE+P into the due diligence and term sheet negotiations process, that DOE will offer a term sheet or that the terms and conditions of a term sheet will be consistent with terms proposed by the applicant. The foregoing matters are wholly dependent on the results of the DOE review and evaluation of a Part II application and DOE’s determination whether to proceed.

About California Ethanol + Power (CE+P)

CE+P is a development company that intends to develop, construct, operate and own numerous facilities that will convert locally grown sugarcane into Essential Ethanol ^™ sustainable, renewable, and extremely low carbon transportation fuel that will assist California in meeting its groundbreaking AB32 requirements. CE+P is committed to employing processes and equipment that are both commercially proven and financeable, while also meeting California’s stringent environmental regulations.

Florida Museum of Photographic Arts announces a call for entries for the 2022 International Photography Competition

• All entries must be received by May 9, 2022
• Best in Competition winner will receive $1,000 and consideration for a solo exhibition at FMoPA
• The winning images will be on view at FMoPA from June 10 through July 17, 2022

Florida Museum of Photographic Arts (FMoPA) is announcing a call for entries to its annual 2022 International Photography Competition.

The winners will be selected in seven categories: Conceptual; Abstract; Still Life; Documentary/Photojournalism; Nature/Science/ Animals; Places/Landscapes/Drone; People/Portraits. A flagship project of the Florida Museum of Photographic Arts, the International Photography Competition has been running for two decades commemorating the museum’s commitment to positioning photographic art as central to everyday life and culture. The competition is sponsored by Hahnemühle FineArt GmbH and Blick Art Materials.

To submit entries to the competition, please visit bit.ly/3tggQOM

Photo entries will be judged based on originality, technical excellence, composition, overall impact, artistic merit, and otherwise determined by the judges. Every 2022 International Photography Competition (IPC 2022) winner will have their images printed and displayed as part of a group exhibition in the FMoPA Community Gallery. In addition, this year’s Best in Competition winner will receive $1,000 and consideration for a solo exhibition at FMoPA. All winning entries will be considered for featuring in FMoPA’s promotional materials.

Last year, the panel of jurors selected 21 winning images from over 1,200 submissions. Los Angeles-based artist Austin Irving was named Best in Competition for her dramatic depiction of the Dau Go cave in Halong Bay, Vietnam, which explores the humans-first approach of modern tourism.

About FMoPA

Florida Museum of Photographic Arts (FMoPA)is a museum dedicated to exhibiting important photographic art as central to contemporary life and culture. FMoPA also enriches the community by operating outreach programs to educate children and adults. Founded in 2001, FMoPA occupies the atrium of the architecturally-significant Cube building in Tampa’s Waterfront Arts District. FMoPA is one of fewer than ten museums in the United States dedicated exclusively to photography and one of two such museums in Florida. The museum is home to high-impact community programs, such as the Children’s Literacy through Photography program for at-risk children, as well as adult photography classes, workshops, and children’s summer camps. For more information, please visit  www.fmopa.org

ROTTERDAM, the 7th of April 2022 – International real estate crowdfunding platform Max Crowdfund, launched in 2020, successfully raised more than €21 million for real estate developers and has over 7,000 registered users. The platform also raised €4.25 million in an equity round during 2021 and is putting this money to good use, as they have already increased its transaction volume by tenfold within one year. With this enormous growth, Max Crowdfund continues to break its records, and the platform had a fantastic start of 2022.

On the 10th of January 2022, the platform raised €786,500 within one day. Shortly after that, two new records were set within one loan, as a total of €1.24 million was raised by 421 investors in 22 days for one real estate project. This was the largest loan to date and was subscribed by the highest number of investors. On the 6th of April 2022, three loans went live on the platform. The first loan was published at 9.00 am and was fully funded within one hour by 160 investors. The second loan, published at noon, was funded within 7 minutes by 107 investors. Last but not least, the third loan of that day went live at 2.00 pm and was funded by 99 investors within just 2 minutes! Again, this demonstrates new records are being broken.

The Dutch and New Zealand financial authorities currently authorised the Max Crowdfund platform to market real estate backed loans in the Netherlands, Belgium, Germany, New Zealand and the United Kingdom. The future target of the ambitious founders is to publish bigger loans in as many countries as possible. To achieve this, Max Crowdfund will submit their EU Crowdfunding license application. Max Crowdfund can expand into all EU countries and offer investment opportunities to all EU citizens with this license. Both retail and sophisticated investors can invest in all the real estate investment opportunities on the platform.

The successfully closed equity round was for this exact expansion program, and Max Crowdfund works with local partners in each interesting country. ¨With our joint venture model, we eventually want to launch Max Crowdfund in every country where it is possible¨, says CEO Felix Berkhout. Investors can start investing from as little as €100 on the platform, which truly makes real estate investing accessible to everyone. In addition, Max Crowdfund is the first international real estate crowdfunding platform that uses blockchain technology, and it is their goal to place every fundraiser on the blockchain for transparency purposes.

For more information visit their website and their social channels:

www.maxcrowdfund.com

Facebook

Twitter

Instagram

YouTube

LinkedIn

New York City (April 7, 2022) – When it comes to perpetuating pay inequities in the workplace, one contributing factor may be the very function responsible for leading DEI efforts in most organizations: senior management. That’s according to human resources professionals at 322 US employers who responded to XpertHR’s 2022 Survey on Pay Equity.

The survey underscored the complex nature of the business world’s pay inequity problem, identifying several potential causes that contribute to its persistence.  Of the companies surveyed that self-reported pay inequities within their organizations:

• 53% said senior leadership and individual pay decisions have a high impact on driving pay disparities within their workforce
• 42% attributed pay inequities to talent management; and
• 40% cited individuals’ salary histories or organizational structure.

“The survey results show that senior executives still have great responsibility to lead the change in pay equity in the workplace,” said Zara Nanu, CEO of Gapsquare, an XpertHR company. “Now is the time for company leaders to hold themselves accountable and engage in bold strategies that create real change.”

XpertHR’s survey also investigated effective solutions for ensuring pay equity, asking respondents to identify “somewhat effective” or “very effective” methods. These efforts are broadly categorized as:

• Data-centered: This includes pay equity audits, using analytics to make pay decisions, benchmarking pay equity trends, and conducting employee surveys.
• Training-focused: This includes training managers and others who may be in a position to influence employee pay, as well as providing employees with development opportunities to move into higher-paying roles.
• Transparency- and communication-driven: This includes providing pay ranges in job positing and informing employees of the pay range for their position.

Results also indicated an opportunity to address policies and procedures that could achieve pay equity. Short-term actions such as one-time pay adjustments (90%) and annual incentive program revisions (87%) were cited as effective means for ensuring pay equity. Hiring manager training (82%) and development opportunities for employees (79%) were identified as longer-term strategies for eliminating barriers to equal pay.

However, although many measures were highly rated for their perceived effectiveness, the use of these methods varied widely between responding organizations. For instance, while 93% of respondents endorsed using analytics for making pay decisions, just 38% actually did so.

“Data is a powerful resource that employers can use to hold themselves accountable and uncover the truth of what they are doing to address pay equity,” Nanu continued. “When paired with other key measures related to internal and industry-wide policy changes, elevated accountability and flexibility, businesses can enact genuine, meaningful change and work toward achieving transformational pay equity.”

XpertHR’s Survey on Pay Equity 2022 was conducted from Jan. 25-Feb. 11, 2022. The survey includes the responses from 322 US employers from various industries and workforce sizes. The total number of employees of responding organizations is 829,374. The survey addressed several topics including drivers of pay inequity, measures used to ensure pay equity and their effectiveness, what function leads pay equity efforts, and more.

About XpertHR:

XpertHR has been providing HR solutions since 2002, empowering organizations across the globe to build successful workforces and create a purposeful workplace for all. The platform delivers expert insight, trusted resources, data analysis and practical tools to help achieve greater efficiency, reduce risk, and increase employee engagement. XpertHR is developing smarter data analysis tools and cutting-edge technology to support future demands on HR in an increasingly digital world. To learn more visit xperthr.com.

About Gapsquare:

Gapsquare is at the forefront of pay equity and wage analytics. Its innovative software Gapsquare™ Pro provides businesses with instant insights into wage gaps across various demographics, such as gender, race/ethnicity, disability and sexual orientation. Gapsquare’s mission is to create a fairer world of work: one where work is inclusive, where pay meets value and diverse talent thrives. To learn more visit Gapsquare.com.